Kathryn L Ponder1, Alicia Bárcena2, Frank L Bos3, Matthew Gormley2, Yan Zhou2, Katherine Ona2, Mirhan Kapidzic2, Ann C Zovein4, Susan J Fisher2. 1. Division of Neonatology, Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA kathryn.ponder@ucsf.edu. 2. Department of Obstetrics, Gynecology and Reproductive Sciences, Center for Reproductive Sciences, Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California San Francisco, San Francisco, CA, USA. 3. Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA. 4. Division of Neonatology, Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA.
Abstract
BACKGROUND: The human placenta is a source of hematopoietic stem and progenitor cells (HSPCs). The RUNX1 transcription factor is required for the formation of functional HSPCs. The impact of preeclampsia (PE) and preterm labor (PTL, spontaneous preterm labor [sPTL] and inflammatory preterm labor [iPTL]) on HSPC localization and RUNX1 expression in the human placenta is unknown. METHODS: We compared the frequency and density of HSPC in control samples from sPTL (n = 6) versus PE (n = 6) and iPTL (n = 6). We examined RUNX1 protein and RNA expression in placentas from normal pregnancies (5-22 weeks, n = 8 total) and in placentas from the aforementioned pregnancy complications (n = 5/group). RESULTS: Hematopoietic stem and progenitor cells were rare cell types, associated predominantly with the vasculature of placental villi. The HSPC density was greater in the chorionic plate (CP) compared to the villi (P < .001) and greater in PE and iPTL samples as compared to controls within the CP (not significant) and overall (P < .05). During the fetal period, RUNX1 was expressed in the mesenchyme of the CP and villi. Inflammatory PTL samples were more likely to exhibit intraluminal RUNX1(+) cell populations (P < .001) and RUNX1(+) cell clusters attached to arterial endothelial cells. CONCLUSION: Placental HSPCs likely arise from hematopoietic niches comprised RUNX1(+) mesenchyme and vascular endothelium. Pregnancy complications that result in preterm birth differentially affect placental HSPC localization and RUNX1 expression. Our results support previous findings that inflammation positively regulates hematopoiesis. We present new evidence that hemogenic endothelium may be active at later stages of human fetal development in the context of inflammation.
BACKGROUND: The human placenta is a source of hematopoietic stem and progenitor cells (HSPCs). The RUNX1 transcription factor is required for the formation of functional HSPCs. The impact of preeclampsia (PE) and preterm labor (PTL, spontaneous preterm labor [sPTL] and inflammatory preterm labor [iPTL]) on HSPC localization and RUNX1 expression in the human placenta is unknown. METHODS: We compared the frequency and density of HSPC in control samples from sPTL (n = 6) versus PE (n = 6) and iPTL (n = 6). We examined RUNX1 protein and RNA expression in placentas from normal pregnancies (5-22 weeks, n = 8 total) and in placentas from the aforementioned pregnancy complications (n = 5/group). RESULTS: Hematopoietic stem and progenitor cells were rare cell types, associated predominantly with the vasculature of placental villi. The HSPC density was greater in the chorionic plate (CP) compared to the villi (P < .001) and greater in PE and iPTL samples as compared to controls within the CP (not significant) and overall (P < .05). During the fetal period, RUNX1 was expressed in the mesenchyme of the CP and villi. Inflammatory PTL samples were more likely to exhibit intraluminal RUNX1(+) cell populations (P < .001) and RUNX1(+) cell clusters attached to arterial endothelial cells. CONCLUSION: Placental HSPCs likely arise from hematopoietic niches comprised RUNX1(+) mesenchyme and vascular endothelium. Pregnancy complications that result in preterm birth differentially affect placental HSPC localization and RUNX1 expression. Our results support previous findings that inflammation positively regulates hematopoiesis. We present new evidence that hemogenic endothelium may be active at later stages of human fetal development in the context of inflammation.
Authors: Vladimir Serikov; Catherine Hounshell; Sandra Larkin; William Green; Hirokazu Ikeda; Mark C Walters; Frans A Kuypers Journal: Exp Biol Med (Maywood) Date: 2009-05-08
Authors: Raquel Espín-Palazón; David L Stachura; Clyde A Campbell; Diana García-Moreno; Natasha Del Cid; Albert D Kim; Sergio Candel; José Meseguer; Victoriano Mulero; David Traver Journal: Cell Date: 2014-11-06 Impact factor: 41.582
Authors: Maggie L Kalev-Zylinska; Julia A Horsfield; Maria Vega C Flores; John H Postlethwait; Jackie Y M Chau; Peter M Cattin; Maria R Vitas; Philip S Crosier; Kathryn E Crosier Journal: Dev Dyn Date: 2003-11 Impact factor: 3.780
Authors: Anshul Kundaje; Wouter Meuleman; Jason Ernst; Misha Bilenky; Angela Yen; Alireza Heravi-Moussavi; Pouya Kheradpour; Zhizhuo Zhang; Jianrong Wang; Michael J Ziller; Viren Amin; John W Whitaker; Matthew D Schultz; Lucas D Ward; Abhishek Sarkar; Gerald Quon; Richard S Sandstrom; Matthew L Eaton; Yi-Chieh Wu; Andreas R Pfenning; Xinchen Wang; Melina Claussnitzer; Yaping Liu; Cristian Coarfa; R Alan Harris; Noam Shoresh; Charles B Epstein; Elizabeta Gjoneska; Danny Leung; Wei Xie; R David Hawkins; Ryan Lister; Chibo Hong; Philippe Gascard; Andrew J Mungall; Richard Moore; Eric Chuah; Angela Tam; Theresa K Canfield; R Scott Hansen; Rajinder Kaul; Peter J Sabo; Mukul S Bansal; Annaick Carles; Jesse R Dixon; Kai-How Farh; Soheil Feizi; Rosa Karlic; Ah-Ram Kim; Ashwinikumar Kulkarni; Daofeng Li; Rebecca Lowdon; GiNell Elliott; Tim R Mercer; Shane J Neph; Vitor Onuchic; Paz Polak; Nisha Rajagopal; Pradipta Ray; Richard C Sallari; Kyle T Siebenthall; Nicholas A Sinnott-Armstrong; Michael Stevens; Robert E Thurman; Jie Wu; Bo Zhang; Xin Zhou; Arthur E Beaudet; Laurie A Boyer; Philip L De Jager; Peggy J Farnham; Susan J Fisher; David Haussler; Steven J M Jones; Wei Li; Marco A Marra; Michael T McManus; Shamil Sunyaev; James A Thomson; Thea D Tlsty; Li-Huei Tsai; Wei Wang; Robert A Waterland; Michael Q Zhang; Lisa H Chadwick; Bradley E Bernstein; Joseph F Costello; Joseph R Ecker; Martin Hirst; Alexander Meissner; Aleksandar Milosavljevic; Bing Ren; John A Stamatoyannopoulos; Ting Wang; Manolis Kellis Journal: Nature Date: 2015-02-19 Impact factor: 69.504
Authors: Todd M Everson; Marta Vives-Usano; Emie Seyve; Johanna Lepeule; Marie-France Hivert; Mariona Bustamante; Andres Cardenas; Marina Lacasaña; Jeffrey M Craig; Corina Lesseur; Emily R Baker; Nora Fernandez-Jimenez; Barbara Heude; Patrice Perron; Beatriz Gónzalez-Alzaga; Jane Halliday; Maya A Deyssenroth; Margaret R Karagas; Carmen Íñiguez; Luigi Bouchard; Pedro Carmona-Sáez; Yuk J Loke; Ke Hao; Thalia Belmonte; Marie A Charles; Jordi Martorell-Marugán; Evelyne Muggli; Jia Chen; Mariana F Fernández; Jorg Tost; Antonio Gómez-Martín; Stephanie J London; Jordi Sunyer; Carmen J Marsit Journal: Nat Commun Date: 2021-08-24 Impact factor: 14.919
Authors: Zahra Masoumi; Mary Familari; Karin Källén; Jonas Ranstam; Per Olofsson; Stefan R Hansson Journal: PLoS One Date: 2017-04-28 Impact factor: 3.240
Authors: Padma Priya Togarrati; Nuntana Dinglasan; Elizabeth Yee; John W Heitman; Rachael P Jackman; Mark Geisberg; Philip J Norris; Alicia Bárcena; Marcus O Muench Journal: Transplant Direct Date: 2019-05-29
Authors: Zahra Masoumi; Lena Erlandsson; Eva Hansson; Mattias Magnusson; Eva Mezey; Stefan R Hansson Journal: Int J Mol Sci Date: 2021-03-25 Impact factor: 5.923